Axios @axios
@margarettalev @mmfernandez_ @RepRaulRuizMD @DrMichelleBIO .@RepRaulRuizMD: "Diversity in trials will help motivate, empower institutions to recruit more minority populations, women and other understudied groups in order to ensure that when we do have a treatment or medication, that they also work for those individuals." https://t.co/YnfCe3i0wN — PolitiTweet.org